These results indicated that 12‐LOX promoted angiogenesis and cell proliferation in ESCC through the PI3K/AKT/mTOR pathway and that RAD001 might be a potentially powerful cancer‐preventing agent in ESCC. Here, SPRR2A is linked to esophageal squamous cell carcinoma.